Search results
Results from the WOW.Com Content Network
Left's 2015 report on Valeant Pharmaceuticals (later known as Bausch Health) accused the company of channel stuffing [38] and using sham transactions to inflate drug sales. Left's initial report focused on an investigation launched by Senator Bernie Sanders and Representative Elijah Cummings that examined Valeant's business model of massively ...
[59] [60] In October 2015, the company's Bausch & Lomb division acquired Doctor's Allergy Formula for an undisclosed sum. [61] On October 21, 2015, Citron Research founder Andrew Left, a short seller of Valeant shares, published claims that Valeant recorded false sales of products to specialty pharmacy Philidor Rx Services and its
A federal grand jury has indicted prominent activist short seller Andrew Left on multiple counts of securities fraud for a long-running $16 million market manipulation scheme, the U.S. Justice ...
J. Michael Pearson (born 1959) is a Canadian American [1] pharmaceutical company executive. He is the former chairman and CEO of Valeant Pharmaceuticals International [2] [3] after being ousted in the aftermath of a report on pharmaceutical pricing published by Citron Research in April 2016.
Canadian drugmaker Bausch Health Companies Inc said on Thursday it would spin-off its eye care unit Bausch + Lomb into a separate publicly listed company. Bausch Health, previously known as ...
Andrew Left, who has long targeted companies that he thinks are over-valued through his work at Citron Research, told investors on Monday that his new hedge fund returned 43% after fees in 2019 ...
Bausch Health Companies owns 88.4% of Bausch and Lomb. ... The company forecast its dry-eye business to break $1 billion in sales this year, up from $916 million in 2024.
ISTA Pharmaceuticals, Inc., was a US-based pharmaceutical company that specialized in ophthalmic pharmaceutical products and discovers, develops, and markets therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. [1] ISTA was acquired by Bausch & Lomb, an eye care company, on March 26, 2012. [2]